BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Home > article

Celltrion leaves door open for consignment production of COVID-19 vaccines

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : November 18, 2020, 17:02 | Updated : November 18, 2020, 17:02
  • 트위터
  • 페이스북
  • 웨이보
 

[Courtesy of Celltrion]


SEOUL -- Celltrion, a leading biotech company in South Korea, left the door open for consignment production through cooperation with COVID-19 vaccine producers, saying more than 10 companies worldwide are expected to succeed in developing vaccines in the first half of 2021.

"About 100 companies around the world are developing COVID-19 vaccines, and more than 10 are expected to succeed in the first half of next year," Celltrion Chairman Seo Jung-jin told reporters on the sidelines of a bio-industry event in Songdo west of Seoul. "Celltrion is open to a system of working together to produce COVID-19 vaccines and secure them for domestic use," he added.

Clinical trials are under way to verify the efficacy and safety of Celltrion's COVID-19 antibody treatment, CT-P59. Celltrion has vowed to complete preparations for the mass supply of therapeutic antibodies. Seo said Celltrion would try to obtain conditional approval from the Ministry of Food and Drug for emergency use within this year.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Celltrion wins $185 mln deal to sell rapid COVID-19 test kit to U.S..
    Celltrion wins $185 mln deal to sell rapid COVID-19 test kit…
  • .Celltrion makes preparations for emergency domestic use of COVID-19 antibodies.
    Celltrion makes preparations for emergency domestic use of C…
  • .GC Pharmas plasma treatment allowed for actual use in treating COVID-19 patients.
    GC Pharma's plasma treatment allowed for actual use in treat…
  • .  Celltrion checks antibody treatments effect of COVID-19 infection prevention    .
    Celltrion checks antibody treatment's effect of COVID-19 i…
  • .Celltrion allowed to go ahead with last-stage clinical test of COVID-19 antibody treatment.
    Celltrion allowed to go ahead with last-stage clinical test …

Real Time Photo News

  • .S. Korea to build state-run K-pop concert hall for unaffordable online performances .

    S. Korea to build state-run K-pop concert hall for unaffordable online performances

  • .BLACKPINK member Rosé to release solo album in March.

    BLACKPINK member Rosé to release solo album in March

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

Latest News

more+

  • Aviation industry wants government push to make early preparations for use of biofuels
  • Dongkuk Steel develops antiviral metal plates capable of killing COVID-19 virus in 30 minutes
  • Hyundai Glovis strengthens logistics partnership with China's Changjiu Group
  • Aramco partners with Hyundai shipbuilder to develop business model using hydrogen and ammonia
  • Hancom acquires drone technology startup Awesome Tech
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view